Abstract-We compared systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse pressure (PP), and mean arterial pressure (MAP) in predicting the risk of cardiovascular disease (CVD), stratifying results at age 60 years, when DBP decreases while SBP continues to increase. We prospectively followed 11 150 male physicians with no history of CVD or antihypertensive treatment through the 2-year questionnaire, after which follow-up began. Reported blood pressure was averaged from both the baseline and 2-year questionnaires. During a median follow-up of 10. Key Words: blood pressure Ⅲ coronary artery disease Ⅲ stroke Ⅲ epidemiology Ⅲ aging T he positive association between either systolic blood pressure (SBP) or diastolic blood pressure (DBP) and the risk of cardiovascular disease (CVD) is well established. 1 Blood pressure is also characterized by its pulsatile and steady components. [2] [3] [4] The pulsatile component, estimated by pulse pressure (PP), represents blood pressure variation and is affected by left ventricular ejection fraction, large-artery stiffness, early pulse wave reduction, and heart rate. 5 The steady component, estimated by mean arterial pressure (MAP), is a function of left ventricular contractility, heart rate, and vascular resistance and elasticity averaged over time. 2, 6 It remains unclear which measures of blood pressure, either alone or in combination, best predict the risk of CVD. Data from the Framingham Heart Study 5,7,8 and other studies 9, 10 indicate that SBP increases continuously across all age groups, whereas DBP increases until age 60 years and then begins to decrease steadily. As a result, PP may become a more important blood pressure measure associated with CVD in older individuals. 11 In addition, MAP has not been extensively studied, with positive associations in some, 12-14 but not all, 15 studies with CVD.
T he positive association between either systolic blood pressure (SBP) or diastolic blood pressure (DBP) and the risk of cardiovascular disease (CVD) is well established. 1 Blood pressure is also characterized by its pulsatile and steady components. [2] [3] [4] The pulsatile component, estimated by pulse pressure (PP), represents blood pressure variation and is affected by left ventricular ejection fraction, large-artery stiffness, early pulse wave reduction, and heart rate. 5 The steady component, estimated by mean arterial pressure (MAP), is a function of left ventricular contractility, heart rate, and vascular resistance and elasticity averaged over time. 2, 6 It remains unclear which measures of blood pressure, either alone or in combination, best predict the risk of CVD. Data from the Framingham Heart Study 5, 7, 8 and other studies 9, 10 indicate that SBP increases continuously across all age groups, whereas DBP increases until age 60 years and then begins to decrease steadily. As a result, PP may become a more important blood pressure measure associated with CVD in older individuals. 11 In addition, MAP has not been extensively studied, with positive associations in some, [12] [13] [14] but not all, 15 studies with CVD.
Therefore, we considered the use of SBP, DBP, PP, and MAP in a large cohort of men aged 40 to 84 years at baseline with no history of antihypertensive treatment. Using selfreported average blood pressure values on the baseline and 2-year questionnaires, we compared the associations of each blood pressure measure with the risk of incident CVD. We further examined potential differences in CVD risk by age dichotomized at 60 years, when DBP levels decrease while SBP continues to increase. 3, 5 
Methods

Study Population and Data Collection
The subjects and methods of the Physicians' Health Study, a 2ϫ2 factorial trial of aspirin and ␤-carotene for the primary prevention of CVD or cancer, have been described previously. 16, 17 Briefly, 22 071 US male physicians, aged 40 to 84 years at entry, were enrolled and were free from prior myocardial infarction (MI), stroke, transient ischemic attack, cancer (except non-melanoma skin cancer), current renal or liver disease, peptic ulcer, and gout. Among the 22 071 randomized men, subjects were excluded if they had CVD (nϭ520), any past or current history of antihypertensive medication use (nϭ3460), or any missing data on blood pressure (nϭ4540) or antihypertensive medication use (nϭ2401) on either the baseline or 2-year questionnaires. These exclusions resulted in a study population of 11 150 men.
Self-reported blood pressure is expected to be reliable and valid, since a single measurement of self-reported blood pressure in a different study of physicians was highly correlated with measured SBP (rϭ0.72) and DBP (rϭ0.60). 18 Another study of the agreement of measured and self-reported blood pressure found a correlation similar to that for 2 measurements of blood pressure within a year. 19 We considered 2 other blood pressure measurements besides SBP and DBP. First, we calculated the PP, defined as SBP minus DBP. Second, we calculated the MAP as 1/3(SBP)ϩ2/3(DBP). The average of the baseline and 2-year blood pressure values was used to further minimize any potential misclassification in self-reported blood pressure. On the baseline questionnaire, participants reported other coronary risk factors, including age, smoking status, alcohol use, frequency of vigorous exercise, history of diabetes mellitus, and parental history of MI at Ͻ60 years. Body mass index (in kg/m 2 ) was calculated from height and weight.
Follow-up of the 11 150 participants began after completion of the 2-year questionnaire. On annual follow-up questionnaires, participants were asked whether they had experienced any CVD event since the return of the last questionnaire. CVD events included MI, angina pectoris, coronary artery bypass graft surgery, percutaneous transluminal coronary angioplasty, stroke, and cardiovascular death. For men reporting MI or stroke and for reported deaths, relevant medical records were obtained from Ͼ95% of the participants. Nonfatal MI was diagnosed with the use of World Health Organization criteria. 20 Nonfatal stroke was defined as a typical neurological deficit, sudden or rapid in onset, lasting Ͼ24 hours. CVD death was documented by convincing evidence of a cardiovascular mechanism from death certificates and medical records. All analyses are based on the first CVD event. At the end of follow-up, 99.2% of men still provided morbidity information; mortality follow-up was 99.99% complete. 17 In all, 905 incident CVD cases occurred over a median follow-up of 10.8 years (maximum, 11.2 years).
Data Analysis
All analyses were stratified a priori by baseline ages of Ͻ60 years (nϭ8743) and Ն60 years (nϭ2407). We first determined the mean values or proportions of baseline coronary risk factors according to each group of men. Next, we examined the blood pressure distributions in each subgroup of men. Stratum-specific Spearman correlation coefficients were also computed among the 4 measures of blood pressure.
Two separate analysis strategies sought to determine which measures of average blood pressure predicted the risk of CVD. We first compared equivalent multivariate Cox proportional hazards models that only differed by the measures of average blood pressure used. Seven main models were compared, including SBP only, DBP only, both SBP and DBP, PP only, both PP and DBP, MAP only, and both PP and MAP. Other joint models included SBP and PP, SBP and MAP, and DBP and MAP. Models included terms for age (years), body mass index (kg/m 2 ), randomized aspirin treatment (yes, no), randomized ␤-carotene treatment (yes, no), smoking status (never, past, current Ͻ1 pack/d, current Ն1 packs/d), vigorous exercise Ն1/wk (yes, no), alcohol consumption (Ͻ1 drink/wk, 1 to 6 drinks/wk, Ն1 drink/d), parental history of MI at Ͻ60 years (yes, no), and history of diabetes mellitus (yes, no). Use of finer categories of physical activity did not appreciably change the results. Although we did not control for self-reported lipid levels because data were missing in Ͼ10% of participants, 21 additional control for history of hyperlipidemia (self-reported or measured cholesterol Ͼ260 mg/dL) had little effect on the results. We calculated relative risks (RRs) and 95% CIs, assuming a 10-mm Hg increase in each blood pressure measure. All probability values were 2-tailed ␣ϭ0.05. Nested blood pressure models were compared with the 2 test statistic from likelihood ratio tests.
Our second analysis strategy examined the individual effects of average SBP, DBP, PP, and MAP. Each blood pressure measure was categorized into quartiles for each subgroup of men. Cox proportional hazards models were used to calculate the RR of CVD, with the first quartile as the reference group. We also compared the Ն95th versus Ͻ25th percentiles. Multivariate models adjusted for the same coronary risk factors as before. The assumption of proportional hazards was confirmed in all models (all PϾ0.05) by Wald tests for the interaction of time with each measure of blood pressure. A linear trend across quartiles of blood pressure was tested with an ordinal variable, using median blood pressure levels within each quartile.
We also considered joint models of average SBP and DBP. Average SBP was categorized into Ͻ120, 120 to Ͻ130, 130 to Ͻ140, and Ն140 mm Hg, and average DBP was categorized into Ͻ70, 70 to Ͻ80, 80 to Ͻ90, and Ն90 mm Hg. The reference group included men with average SBP Ͻ120 mm Hg and average DBP Ͻ70 mm Hg. In sensitivity analyses, we considered other age cut points besides age 60 years. Separate multivariate models for each blood pressure measure were considered for men aged 40 to 49, 50 to 59, 60 to 69, and Ն70 years. Effect modification by age was assessed by examining the interaction between age (classified as an ordinal variable using median values from categories of 40 to 49, 50 to 59, 60 to 69, and Ն70 years) and each average blood pressure measure in multivariate models. We then examined whether the association between blood pressure and risk of CVD was similar for men with any history of hypertension treatment. Finally, the RRs for stroke (200 cases) were compared with the overall results for CVD.
Results
The mean (ϮSD) levels of average SBP, DBP, PP, and MAP for all 11 150 men (mean age, 52.3 years) were 124.1Ϯ11.1, 77.5Ϯ7.1, 46.6Ϯ8.8, and 93.0Ϯ7.6 mm Hg, respectively. Table 1 compares the blood pressure parameters and other baseline characteristics of men aged Ͻ60 and Ն60 years. As expected, men aged Ն60 years had higher levels of average SBP, PP, and MAP than men aged Ͻ60 years. Average DBP in men aged Ն60 years was similar to that in men aged Ͻ60 years. There were 5.3% and 16.8% of men aged Ͻ60 and Ն60 years, respectively, who had an average SBP Ն140 mm Hg or DBP Ն90 mm Hg despite reporting no history of antihypertensive treatment.
Spearman correlations between average SBP and DBP were 0.70 and 0.61 in men aged Ͻ60 and Ն60 years (both PϽ0.001). Average SBP and DBP were each highly correlated with MAP, with Spearman correlations ranging from 0.88 to 0.94 (all PϽ0.001) in all men. Average DBP was weakly correlated with PP, with Spearman correlations of 0.03 and 0.06 in men aged Ͻ60 and Ն60 years, respectively. All other combinations of blood pressure measures were highly correlated.
During 112 384 person-years of follow-up (median followup, 10.8 years), we identified 905 total cases (Ͻ60 years, 509 cases; Ն60 years, 396 cases) of incident CVD. To reduce any potential bias due to underlying illnesses that may have affected their blood pressure levels, the exclusion of men with CVD during the first 3 years of follow-up did not materially alter the results. Additional adjustment for coronary risk factors other than age had a small relative impact on the RRs for blood pressure. There were 204 men (22 cases of CVD) who were excluded from multivariate models because of missing coronary risk factor data besides age; however, a comparison of age-adjusted models with and without these subjects did not affect the RRs. For all Cox proportional hazards models in Tables 2 and 3, adjustment We next examined similar multivariate models in Table 4 but based on quartiles of average SBP, DBP, PP, and MAP. In men Ͻ60 years, average SBP, DBP, and MAP all had strong associations with CVD risk. Men in the highest versus lowest quartiles of average SBP (Ն130 versus Ͻ116 mm Hg), DBP (Ն81 versus Ͻ73 mm Hg), and MAP (Ն97 versus Ͻ88 mm Hg) had RRs of CVD of 2.16, 2.23, and 2.52, respectively. An increased risk of CVD was evident in men aged Ͻ60 years in the second quartile of SBP, DBP, and MAP. In men aged Ն60 years, increasing quartiles of SBP and PP were strongly associated with the risk of CVD. Comparing the highest versus lowest quartiles of average SBP (Ն135 versus Ͻ120 mm Hg) and PP (Ն55 versus Ͻ44 mm Hg), the corresponding RRs were 1.69 and 1.83. MAP was also associated with the risk of CVD, but with RRs of lower magnitude.
Finally, we examined the joint effect of average SBP and DBP with the CVD risk in men aged Ͻ60 and Ն60 years after adjustment for coronary risk factors. In men aged Ͻ60 years, single category increases in average SBP (from Ͻ120 to the category 120 to Ͻ130 mm Hg) or DBP (from Ͻ70 to the category 70 to Ͻ80 mm Hg) resulted in a 2-or 3-fold increase in CVD risk. In men aged Ն60 years, there were similar patterns of an increased CVD risk but of a lower magnitude. Older men with greater PPs (average SBP 130 to Ͻ140 and DBP Ͻ70 mm Hg) had the highest RR of CVD.
In sensitivity analyses, we also considered age stratified into 4 age groups (Ͻ50, 50 to 59, 60 to 69, and Ն70 years) and compared the age-specific, multivariate RRs of CVD for 10-mm Hg increases in individual blood pressure measures (Figure ) . There was a pattern of declining RRs with age for average SBP, DBP, and MAP but not for average PP. These results were further supported by significant interactions found between categories of age and either SBP (Pϭ0.004), DBP (Pϭ0.013), or MAP (Pϭ0.01). The largest reductions in effect sizes with age were for average DBP and MAP, which primarily occurred from ages 50 to 59 to 60 to 69 years. Among other subanalyses, the association between blood pressure and stroke (205 cases) yielded RRs similar to those for CVD, although the smaller number of strokes greatly diminished power. We then considered the associations between blood pressure measures and CVD among men with any past or present history of antihypertensive treatment at baseline. The RRs of CVD for 10-mm Hg increases in SBP (men Ͻ60 years, 1.18; men Ն60 years, 1.28), DBP (men Ͻ60 years, 1.12; men Ն60 years, 1.24), PP (men Ͻ60 years, 1.19; men Ն60 years, 1.20) , and MAP (men Ͻ60 years, 1.21; men Ն60 years, 1.44) were somewhat different than the results in Tables 2 and 3 .
Discussion
We found modest differences according to age for the relationship between blood pressure and CVD risk in men with no history of antihypertensive treatment after comparing models with 4 different blood pressure measures. Average SBP, DBP, and MAP were all strongly associated with an increased CVD risk in younger men. However, average DBP was not associated with CVD risk in men aged Ն60 years. Average PP was associated with the risk of CVD in both younger and older men.
This study of middle-aged and older men was sufficiently powered to examine the association between various blood pressure measures and risk of CVD. Because we excluded men with any history of antihypertensive treatment, these male physicians had a lower distribution of blood pressure values compared with other community-based cohorts. 5, 22 Still, in men aged Ͻ60 years, we found an increased CVD risk among men starting in the second quartile of average SBP (Ն116 mm Hg), DBP (Ն73 mm Hg), and MAP (Ն88 mm Hg). In addition to average SBP, PP emerged with a strong positive association with the risk of CVD in men aged Ն60 years. Despite somewhat lower but elevated RRs in men aged Ն60 years, their greater incidence of CVD underscores the potentially large public health impact of elevated yet untreated blood pressure in the elderly.
When we considered SBP and DBP simultaneously, only SBP remained significant in multivariate models for men aged Ͻ60 and Ն60 years. During the seventh decade of life, age-specific SBP levels continue to increase, while DBP levels begin to decline. 5, [7] [8] [9] [10] We found no independent association between average DBP and CVD risk in men aged Ն60 years. This loss of predictive value for average DBP may be due to an increasing number of men with underlying illnesses 23 ; however, we would have expected fewer such men in our cohort of apparently healthy male physicians. Isolated systolic hypertension becomes more prevalent with age and has been associated with a significant, increased risk of CVD. 21, 24 Increases in PP are associated with aging, particularly after age 60 years. 5, 10 Higher levels of PP have been associated with carotid stenosis, 15 left ventricular hypertrophy, 25 MI, 3,26 -28 CVD death, 12, 29 and congestive heart failure 30 in both normotensive and hypertensive populations. Studies in older men and women have found that PP remains important even after controlling for either SBP or DBP. 11, 15, 30 Our results for average PP in older, but not younger, men were consistent with these findings.
Few studies have prospectively addressed the effect of MAP in relation to CVD. [12] [13] [14] 28 Dyer et al 13 found that the steady component of blood pressure (highly correlated with MAP) was more strongly associated with CVD risk than PP in 4 Chicago epidemiological studies. Among subjects with a history of MI, one study indicated a significant 12% increase in recurrent MI for each 10-mm Hg increase in MAP. 28 However, MAP was a weaker predictor than PP and was not associated with CVD mortality. We found that MAP may be strongly associated with CVD risk in men aged Ͻ60 years, with a RR of CVD for a 10-mm Hg increase in average MAP of 1.48. This RR was greater than a RR of 1.33 for a comparable 10-mm Hg increase among French men aged 40 to 54 years. 12 Any clinical advantage for MAP, which is a function of SBP and DBP, for the evaluation of CVD risk among younger men remains unclear. Models with any 2 blood pressure parameters yielded identical Ϫ2 log likelihoods for men Ͻ60 and Ն60 years because of the linear relationship between blood pressure variables. In this regard, MAP when used in combination with other blood pressure parameters offers no additional ability to predict the risk of CVD. However, among models with single blood pressure parameters in men aged Ͻ60 years, MAP was a slightly stronger predictor of CVD than SBP based on Ϫ2 log likelihoods. Therefore, in younger men, either MAP or SBP may best predict the risk of CVD when individual blood pressure parameters are considered. Biologically, the magnitude of RRs of CVD for average SBP in men aged Ͻ60 and Ն60 years reflects the strength of its continuous, graded relationship with CVD risk. 1 Higher SBP levels may reflect the progressive stiffening of the arterial wall, changes in the vascular structure, and the development of atherosclerosis. 31 Decreased DBP may indicate poor coronary flow reserve and coronary perfusion of the myocardium. 32 Increases in PP reflect the stiffening of the conduit vessels. Such vessel stiffening increases pulse-wave velocity, which ultimately increases systemic load while decreasing coronary perfusion pressure. 28 MAP is the steady flow of blood through the aorta and its arteries and equals the cardiac output multiplied by vascular resistance. 2 Some limitations should also be considered in light of these results. First, our use of self-reported blood pressure may be subject to misclassification. For example, the weak association between DBP and CVD in men aged Ն60 years may be explained by an underreporting of DBP due to individual differences in recording fourth or fifth Korotkoff sounds. By averaging self-reported blood pressure on the baseline and 2-year questionnaires, we sought to further minimize any misclassification. We excluded men with any history of antihypertensive treatment to reduce any potential confounding by antihypertensive treatment on blood pressure values, although data from Framingham suggest that antihypertensive treatment may not confound the association between blood pressure and coronary heart disease. 11 Next, our findings may not apply to women, lower socioeconomic groups, and non-white populations, who may be more or less susceptible to hypertension and responsive to changes in blood pressure. Finally, unaccounted biochemical, clinical, and genetic markers for the risk of CVD may introduce residual confounding.
In conclusion, among men with no history of antihypertensive treatment, SBP may be best utilized in men aged Ͻ60 years, whereas either SBP or PP may be best suited for men aged Ն60 years. DBP was a strong predictor of CVD in younger, but not older, men. Finally, more research must distinguish whether MAP, which is highly correlated with either SBP or DBP, may be an important predictor of CVD in younger men.
